Phase 3 Study of Umbralisib Combined With Ublituximab vs Obinutuzumab Plus Chlorambucil in Patients With Chronic Lymphocytic Leukemia: Results From UNITY-CLL

Drug Category : Array
Conference Category : Array
Lead Author : Gribben J, et al.
Published Date : 07/12/2020
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2020/12/ASH2020GribbenJU2CLL.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top